Ionis Pharmaceuticals Inc $ 52.40 -1.01 (-1.89%)
On watch
Volume:
1,167,944
Avg Vol (1m):
923,159
Market Cap $:
7.38 Bil
Enterprise Value $:
6.33 Bil
PE Ratio:
0.00
PB Ratio:
8.70
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 2.25 | ||
| Equity-to-Asset | 0.35 | ||
| Debt-to-Equity | 1 | ||
| Debt-to-EBITDA | -7.78 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 3.04 | ||
| Beneish M-Score | -4.4 | ||
| WACC vs ROIC | |||
Profitability Rank | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -23.59 | ||
| Net Margin % | -61.88 | ||
| ROE % | -35.08 | ||
| ROA % | -15.16 | ||
| ROC (Joel Greenblatt) % | -73.31 | ||
| 3-Year Revenue Growth Rate | 8.6 |
IONS
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 8.7 | ||
| PS Ratio | 10.04 | ||
| Price-to-Operating-Cash-Flow | 205.49 | ||
| EV-to-EBIT | -50.61 | ||
| EV-to-EBITDA | -58.66 | ||
| EV-to-Revenue | 8.68 | ||
| Current Ratio | 3.65 | ||
| Quick Ratio | 3.62 | ||
| Days Inventory | 665.56 | ||
| Days Payable | 525.46 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 8.99 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 2.5 | ||
| Price-to-Median-PS-Value | 0.79 | ||
| Earnings Yield (Greenblatt) % | -1.98 |